Journal of Substance Abuse Treatment
Volume 26, Issue 4 , Pages 295-303 , June 2004

Does pregnancy affect outcome of methadone maintenance treatment?

  • Cynthia Crandall, Psy.D.

      Affiliations

    • Corresponding Author InformationCorresponding author. Hennepin Faculty Associates, 914 South 8th Street, Ste. D157, Minneapolis, MN 55404, USA. Tel.: +1-612-347-3996; fax +1-612-373-1859
    • Hennepin Women's Mental Health Program, Hennepin Faculty Associates, Minneapolis, Minnesota, USA
    • ,
  • Ross D Crosby, Ph.D.

      Affiliations

    • Neuropsychiatric Research Institute, University of North Dakota School of Medicine, Fargo, North Dakota, USA
    • ,
  • Gregory A Carlson, B.A.

      Affiliations

    • Addiction Medicine Program, Hennepin Faculty Associates, Minneapolis, Minnesota, USA

Received 18 May 2003 ,Revised 16 January 2004 ,Accepted 5 February 2004.

References 

  1. Andres RL. Social and illicit drug use in pregnancy. In:  Creasy RK,  Resnik R editor. Maternal-fetal medicine. 4th ed.,. Philadelphia: W.B. Saunders Company; 1999;p. 145–164
  2. Arfken CL, Klein C, di Menza S, Schuster CR. Gender differences in problem severity at assessment and treatment retention. Journal of Substance Abuse Treatment. 2001;20:53–57
  3. Avants SK, Warburton LA, Margolin A. The influence of coping and depression on abstinence from illicit drug use in methadone-maintained patients. American Journal of Drug and Alcohol Abuse. 2000;26:399–416
  4. Brady KT, Randall CL. Gender differences in substance use disorders. Psychiatric Clinics of North America. 1999;22:241–252
  5. Brienza RS, Stein MD, Chen M, Gogineni A, Sobota PM, Maksad J, et al. Depression among needle exchange program and methadone maintenance clients. Journal of Substance Abuse Treatment. 2000;18:331–337
  6. Brooner RK, King VL, Kidorf M, Schmidt CW, Bigelow GE. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Archives of General Psychiatry. 1997;54:71–80
  7. Brown HL, Britton KA, Mahaffey D, Brizendine E, Hiett K, Turnquest MA. Methadone maintenance in pregnancy: A reappraisal. American Journal of Obstetrics and Gynecology. 1998;179:459–463
  8. Brown VB, Melchior LA, Waite-O'Brien N, Huba GJ. Effects of women-sensitive, long-term residential treatment on psychological functioning of diverse populations of women. Journal of Substance Abuse Treatment. 2002;23:133–144
  9. Carroll KM, Chang G, Behr H, Clinton B, Kosten TR. Improving treatment outcome in pregnant, methadone-maintained women. Results from a randomized clinical trial. American Journal on Addictions. 1995;4:56–59
  10. Chatham LR, Hiller ML, Rowan-Szal GA, Joe GW, Simpson DD. Gender differences at admission and follow-up in a sample of methadone maintenance clients. Substance Use and Misuse. 1999;34:1137–1165
  11. Copeland J, Hall W. A comparison of predictors of treatment drop-out rates of women seeking drug and alcohol treatment in a specialist women's and two traditional mixed-sex treatment services. British Journal of Addiction. 1992;87:883–890
  12. Daley M, Argeriou M, McCarty D. Substance abuse treatment for pregnant women: A window of opportunity?. Addictive Behaviors. 1998;23:239–249
  13. Edelin KC, Gurganious L, Golar K, Oellerich D, Kyei-Aboagye K, Hamid MA. Methadone maintenance in pregnancy: consequences to care and outcomes. Obstetrics Gynecology. 1988;71:399–404
  14. Farrell M, Ward J, Mattick R, Hall W, Stimson GV, des Jarlais D, et al. Fortnightly review: Methadone maintenance treatment in opiate dependence: A review. British Medical Journal. 1994;309:997–1001
  15. Finnegan LP. Treatment issues for opiod-dependent women during the perinatal period. Journal of Psychoactive Drugs. 1991;23:191–201
  16. Finnegan LP. Perinatal substance abuse: Comments and perspectives. Seminars in Perinatology. 1991;15:331–339
  17. Finnegan LP, Kandall SR. Maternal and neonatal effects of alcohol and drugs. In:  Lowinson JH,  Ruiz P,  Millman RB,  Langrod JG editor. Substance abuse: A comprehensive textbook. Baltimore, MD: Williams & Wilkins; 1997;p. 513–534
  18. First MB, Spitzer RL, Gibbon M, Williams JB. Structured clinical interview for axis I DSM-IV disorders—Patient edition. New York: Biometrics Research Department, New York State Psychiatric Department; 1994;
  19. First MB, Spitzer RL, Gibbon M, Williams JB, Benjamin L. Structured clinical interview for DSM-IV axis II personality disorders. New York: Biometrics Research Department, New York State Psychiatric Department; 1994;
  20. Fletcher BW, Tims FM, Brown BS. Drug abuse treatment outcome study (DATOS): Treatment evaluation research in the United States. Psychology of Addictive Behaviors. 1997;11:216–229
  21. Halikas JA, Crosby RD. Measuring outcome in the treatment of cocaine abuse: The Drug Impairment Rating Scale for Cocaine. Journal of Addictive Diseases. 1991;11:121–138
  22. Hoegerman G, Schnoll S. Narcotic use in pregnancy. Clinics in Perinatology. 1991;18:51–76
  23. Hubbard RL, Craddock SG, Flynn PM, Anderson J, Etheridge RM. Overview of 1-year follow-up outcomes in the drug abuse treatment outcome study (DATOS). Psychology of Addictive Behaviors. 1997;11:261–278
  24. Jarvis MA, Schnoll SH. Methadone use during pregnancy. NIDA Research Monograph. 1995;149:58–79
  25. Joseph H, Stancliff S, Langrod J. Methadone maintenance treatment (MMT): A review of historical and clinical issues. Mount Sinai Journal of Medicine. 2000;67:347–364
  26. Kaltenbach K, Berghella V, Finnegan L. Opiod dependence during pregnancy: Effects and management. Obstetrics and Gynecology Clinics of North America. 1998;25:139–151
  27. Kandall SR, Doberczak TM, Jantunen M, Stein J. The methadone maintained pregnancy. Clinics in Perinatology. 1999;26:173–183
  28. Khantzian EJ, Treece C. DSM-III psychiatric diagnosis of narcotic addicts: Recent findings. Archives of General Psychiatry. 1985;42:1067–1071
  29. Kissin WB, Svikis DS, Morgan GD, Haug NA. Characterizing pregnant drug-dependent women in treatment and their children. Journal of Substance Abuse Treatment. 2001;21:27–34
  30. Laken MP, Ager JW. Effects of case management on retention in prenatal substance abuse treatment. American Journal of Drug and Alcohol Abuse. 1996;22:439–448
  31. Marcus J, Hans SL, Patterson CB, Morris AJ. A longitudinal study of offspring born to methadone-maintained women. I. Design, methodology, and description of women's resources for functioning. American Journal of Drug and Alcohol Abuse. 1984;10:135–169
  32. McLellan AT, Arndt IO. The effects of psychosocial services in substance abuse treatment. Journal of the American Medical Association. 1993;269:1953–1959
  33. McLellan AT, Alterman AI, Metzger DS, Grissom GR, Woody GE, Luborsky L, et al. Similarity of outcome predictors across opiate, cocaine, and alcohol treatments: Role of treatment services. Special section: The nature and treatment of alcoholism. Journal of Consulting and Clinical Psychology. 1994;62:1141–1158
  34. McLellan AT, Luborsky L, O'Brien CP, Woody GE. An improved evaluation instrument for substance abuse patients: The Addiction Severity Index. The Journal of Nervous and Mental Disease. 1980;168:26–33
  35. McLellan AT, Luborsky L, Woody GE, Druley KA, O'Brien CP. Predicting response to alcohol and drug abuse treatments. Archives of General Psychiatry. 1983;40:620–625
  36. National Institutes of Health Consensus Conference . Effective medical treatment of opiate addiction. Journal of the American Medical Association. 1998;280:1936–1943
  37. Nelson-Zlupko L, Dore MM, Kauffman E, Kaltenbach K. Women in recovery: Their perceptions of treatment effectiveness. Journal of Substance Abuse Treatment. 1996;13:51–59
  38. O'Connor PG, Fiellin D. Pharmacologic treatment of heroin-dependent patients. Annals of Internal Medicine. 2000;133:40–54
  39. Rounsaville BJ, Kosten TR, Weissman MM, Kleber HD. Prognostic significance of psychopathology in treated opiate addicts. Archives of General Psychiatry. 1986;43:739–745
  40. Sloan D. The treatment of opiate addiction during pregnancy. Irish Medical Journal. 1998;91:164–166
  41. Strain EC. Assessment and treatment of comorbid psychiatric disorders in opioid-dependent patients. Clinical Journal of Pain. 2002;18:14–27
  42. Substance Abuse and Mental Health Services Administration . Summary of findings from the 2001 National Household Survey on Drug Abuse. Rockville, MD: Office of Applied Studies; 2001;
  43. United Nations Office for Drug Control and Crime Prevention . Global illicit drug trends. (United Nations Publication Sales No. E.02.XI.9, ISBN 92-1-148150-3). Vienna, Austria: Vienna International Center; 2002;
  44. Ward J, Hall W, Mattick RP. Role of maintenance treatment in opioid addiction. The Lancet. 1999;353:221–226
  45. Williams A. When the client is pregnant: Information for counselors. Journal of Substance Abuse Treatment. 1985;2:27–34

PII: S0740-5472(04)00006-6

doi: 10.1016/j.jsat.2004.02.001

Journal of Substance Abuse Treatment
Volume 26, Issue 4 , Pages 295-303 , June 2004

Article Tools

* Image Usage & Resolution